Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glutamate receptor, ionotropic, N-methyl D-aspartate 1 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0092 | 0.6794 | 1 |
Echinococcus granulosus | glutamate receptor ionotrophic AMPA 3 | 0.0029 | 0.0587 | 0.0575 |
Brugia malayi | Glutamate receptor 2 precursor | 0.0024 | 0.0133 | 0.5 |
Entamoeba histolytica | modulator of drug activity B homolog, putative | 0.0023 | 0 | 0.5 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0104 | 0.8037 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0092 | 0.6794 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0092 | 0.6794 | 1 |
Loa Loa (eye worm) | glutamate receptor 1 | 0.0024 | 0.0133 | 0.5 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0029 | 0.0587 | 0.0575 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0029 | 0.0587 | 0.0575 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0092 | 0.6794 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0 | 0.5 |
Echinococcus multilocularis | glutamate receptor NMDA | 0.0095 | 0.715 | 0.8879 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0092 | 0.6794 | 1 |
Echinococcus granulosus | glutamate receptor 2 | 0.0029 | 0.0587 | 0.0575 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0092 | 0.6794 | 1 |
Echinococcus granulosus | glutamate receptor NMDA | 0.0095 | 0.715 | 0.8879 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0029 | 0.0587 | 0.0575 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0092 | 0.6794 | 0.5 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0029 | 0.0587 | 0.0575 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0092 | 0.6794 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0092 | 0.6794 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0092 | 0.6794 | 1 |
Echinococcus multilocularis | glutamate receptor, ionotrophic, AMPA 3 | 0.0029 | 0.0587 | 0.0575 |
Echinococcus multilocularis | glutamate receptor 2 | 0.0029 | 0.0587 | 0.0575 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0092 | 0.6794 | 1 |
Brugia malayi | Glutamate receptor 1 precursor | 0.0024 | 0.0133 | 0.5 |
Entamoeba histolytica | iron-sulfur flavoprotein, putative | 0.0023 | 0 | 0.5 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0104 | 0.8037 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0092 | 0.6794 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0092 | 0.6794 | 1 |
Loa Loa (eye worm) | glutamate receptor 2 | 0.0024 | 0.0133 | 0.5 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0092 | 0.6794 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0069 | 0.4531 | 0.6669 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0092 | 0.6794 | 1 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0029 | 0.0587 | 0.0575 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0092 | 0.6794 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0092 | 0.6794 | 0.5 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.01 | 0.7605 | 0.9453 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0029 | 0.0587 | 0.0575 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0092 | 0.6794 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0092 | 0.6794 | 1 |
Echinococcus granulosus | nmda type glutamate receptor | 0.01 | 0.7605 | 0.9453 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 11 uM | Antagonist activity at wild type NR1/NR2B receptor expressed in Xenopus oocytes assessed as inhibition of agonist-induced current amplitude by two-electrode voltage-clamp method | ChEMBL. | 20692832 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.